Attorneys Handling National AndroGel Lawsuit Claims Announce AndroGel Lawsuit News Update at AndroGelTestosteroneLawsuitCenter.com

An August 22 Case Management Conference addresses discovery and the AndroGel lawsuit case list swells over 200; The Onder Law Firm is accepting new AndroGel lawsuit claims and offering no-obligation AndroGel lawsuit case review.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

James G. Onder

St. Louis, MO (PRWEB) August 26, 2014

AndroGel lawsuits filed as part of the Testosterone Replacement Therapy Products Liability Litigation, MDL No. 2545, continue to grow in number, report attorneys handling AndroGel lawsuit claims for The Onder Law Firm. According to court documents* available on August 25, 2014, the ¬multi-district litigation (MDL) for AndroGel lawsuit cases now includes at least 209 cases. While court proceedings continue to move forward, new AndroGel Lawsuit claims will still be accepted.

According to court documents from the Northern District of Illinois U.S. District Court where AndroGel lawsuit cases have been consolidated, the parties met on August 22, 2014 to discuss routine matters related to discovery, leadership responsibilities, and coordination between the U.S District Court litigation and AndroGel lawsuit claims in State Courts. The Judge overseeing the AndroGel lawsuit MDL is the Honorable Matthew F. Kennelly.

AbbVie, Inc. is the defendant most frequently named in AndroGel lawsuit claims filed through MDL No. 2545. However, several other companies are included as defendants, according to the most recent case list. Other defendants include Actavis, Inc., Endo Pharmaceuticals, Inc., Pfizer, Inc., Auxilium Pharmaceuticals, Inc., Pharmacia & Upjohn Company, Inc., Abbott Laboratories, Acrux, Ltc., Eli Lilly & Co., and Fagron, Inc.

AndroGel lawsuit claims address the risk of heart attack, stroke, and other cardiovascular problems associated with AndroGel and other testosterone drugs. Approved specifically to treat hypogonadism, or the absence of serum testosterone in males, testosterone products are now widely prescribed in the United States. In two distinct FDA warnings on AndroGel and other testosterone drugs, federal regulators have warned that excessive arterial and venous blood clots are a risk of testosterone drugs such as AndroGel. Heart attack and stroke are side effects linked to arterial blood clots, the subject of an FDA warning from January 31, 2014.* Deep vein thrombosis and pulmonary embolism are health conditions that can be caused by venous blood clots. This health condition and its connection to AndroGel and other testosterone drugs is outlined in another FDA warning, from June 19, 2014. **

MDL No. 2545 includes AndroGel lawsuit claims for arterial blood clot problems only, including plaintiffs who have suffered from heart attack and stroke.

The AndroGelTestosterone Lawsuit Center website offers comprehensive information on AndroGel lawsuit claims and provides regular AndroGel lawsuit news updates from The Onder Law Firm. Based in St. Louis, the firm is known for its success representing individuals against major corporation through pharmaceutical, product liability, and personal injury lawsuits. Individuals who believe they may have grounds to file an AndroGel lawsuit for heart attack or stroke may contact the firm for a free AndroGel lawsuit case review through the website.

No amount of money can compensate families effectively for the loss of loved one, but filing an AndroGel lawsuit may help increase consumer safety. Lawyers handling AndroGel lawsuit claims at The Onder Law Firm believe qualifying persons may be entitled to real compensation and offer no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to AndroGel. Interested persons may contact the firm via its AndroGel Testosterone Lawsuit Center website.

The Onder Law Firm welcomes AndroGel lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling AndroGel lawsuits at http://www.AndroGelTestosteroneLawsuitCenter.com.

*In re: Testosterone Replacement Therapy Products Liability Litigation
**fda.gov/drugs/drugsafety/ucm401746.htm
***fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm


Contact

  • Michael Gudeman
    Gudeman Group
    +1 (314) 614-8709
    Email